Concepedia

Author

Yvonne Y. Yip

Eli Lilly (United States)

Also Known As

Yvonne Y. Yip, Yvonne Yip

15

Publications

273

Citations

7

H-Index

11

Concepts

All Affiliations

Eli Lilly (United States)
YY

About

Yvonne Y. Yip is an author at Eli Lilly (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

180

2

Pharmacology

5

5

180

3

Natural Sciences

4

4

155

4

Biochemistry

4

4

155

5

Chemical Biology

1

1

65

Yvonne Y. Yip

×

7

Publications

273

Citations

7

H-Index

YearCitations

Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth

Michèle C. Smith, Mary M. Mader, James A. Cook,

Molecular Cancer Therapeutics

2016

74

Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor

Yvonne Y. Yip, Frantz Victor, Jason Lamar,

Bioorganic & Medicinal Chemistry Letters

2003

65

P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors

Yvonne Y. Yip, Frantz Victor, Jason Lamar,

Bioorganic & Medicinal Chemistry Letters

2004

41

P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors

Frantz Victor, Jason Lamar, Nancy Snyder,

Bioorganic & Medicinal Chemistry Letters

2003

32

P3 cap modified Phe*-Ala series BACE inhibitors

Shuhui Chen, Jason Lamar, Deqi Guo,

Bioorganic & Medicinal Chemistry Letters

2003

25

P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl α-Ketoamide Based HCV Protease Inhibitors

Shuhui Chen, Jason Lamar, Yvonne Y. Yip,

Letters in Drug Design & Discovery

2005

19

P4 cap modified tetrapeptidyl α-ketoamides as potent HCV NS3 protease inhibitors

David X Sun, Lifei Liu, Beverly A. Heinz,

Bioorganic & Medicinal Chemistry Letters

2004

17

Page 1